Is Citral safe in cosmetics?
Citral has a safety rating of "MODERATE" in our database. EU status: restricted. US status: permitted. 8 toxicological study endpoint(s) are available in our database. This ingredient has been reviewed by SCCS Opinion.
Also known as: Lemarome N, 2,6-Octadienal, 3,7-dimethyl-, 3-01-00-03053, BRN 1721871, Caswell No. 221B (+8 more)
INCI: CITRAL
Citral (CAS 5392-40-5) is a cosmetic fragrance functioning as Fragrance. NOAEL 120 mg/kg bw/day (cross-referenced against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: restricted, max 10 ppm in leave-on products, 100 ppm in rinse-off products; GHS signal word WARNING. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety, pharmaceutical, and food safety data.
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Citral.
Calculate MoS for your specific formulation with the MoS Calculator.
8 study endpoints found for Citral. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | 120 mg/kg bw/day | oral | mouse | Carcinogenicity | COSMOS DB |
| NOAEL | 125 mg/kg bw/day | oral | rat | Developmental | COSMOS DB |
| NOAEL | 210 mg/kg bw/day | oral | rat | Carcinogenicity | COSMOS DB |
| NOAEL | 534 mg/kg bw/day | oral | mouse | Short Term Toxicity | COSMOS DB |
| NOAEL | 745 mg/kg bw/day | oral | mouse | Subchronic | COSMOS DB |
| NOAEL | 820 mg/kg bw/day | oral | rat | Subchronic | COSMOS DB |
| NOAEL | =6 mg/kg bw | - | Unspecified | other | EFSA |
| NOAEL | =6 mg/kg bw | - | Unspecified | other | EFSA |
Globally Harmonized System classification per ECHA C&L inventory and ILO/WHO International Chemical Safety Cards.
Official safety assessments from the Scientific Committee on Consumer Safety (SCCS) and Cosmetic Ingredient Review (CIR).
Pre-calculated NOAEL → SED → MoS audit trail for Citral across SCCS product categories, with measured dermal absorption where available.
Contact sensitization data for Citral based on clinical patch test studies and IFRA standards.
Source: ESSCA/IVDK
Skin absorption and penetration characteristics of Citral, relevant to systemic exposure and MoS calculations.
Source: SCCS Opinion
10 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
| Endpoint | Value | Species | Route | Duration | Source |
|---|---|---|---|---|---|
| NEL | =200 mg/kg-day | Rabbit | oral | short-term (developmental) | EPA TSCA 8e |
| NOAEL | =345 mg/kg-day | Rat | oral | chronic | EFSA |
| ADI | <=0.5 mg/kg | Human | oral | - | WHO/JECFA |
| LEL | =335 mg/kg-day | Rat | oral | chronic | EPA ToxRefDB |
| LEL | =345 mg/kg-day | Rat | oral | chronic | EPA ToxRefDB |
| LEL | =790 mg/kg-day | Mouse | oral | chronic | EPA ToxRefDB |
| LEL | =745 mg/kg-day | Mouse | oral | chronic | EPA ToxRefDB |
| LEL | =210 mg/kg-day | Rat | oral | chronic | EPA ToxRefDB |
| LEL | =100 mg/kg-day | Rat | oral | chronic | EPA ToxRefDB |
| LEL | =60 mg/kg-day | Mouse | oral | chronic | EPA ToxRefDB |
Legally binding harmonized classification per Regulation (EC) No 1272/2008 (CLP) Annex VI.
Inserted via ATP: CLP00
Adverse Outcome Pathway data across 5 assays (DPRA, KeratinoSens, hCLAT, LLNA, NESIL) aggregated from public sources.
Source: LLNA: personal communication by RIFM (RIFM DB #52907) | Submitted by RIFM (RIFM DB #42023); DPRA: Bauch et al. 2011 [DOI:10.1016/j.tiv.2011.05.030] | Gerberick et al. 2004 [DOI:10.1093/toxsci/kfh213]; KS: Natsch et al. 2013 [DOI:10.1002/jat.2868] | Bauch et al. 2011 [DOI:10.1016/j.tiv.2011.05.030]; hCLAT: Bauch et al. 2011 [DOI:10.1016/j.tiv.2011.05.030] | Ashikaga et al. 2010 [DOI:10.1177/026119291003800403]; HPPT: [616] Kligman AM (1972): Reports to RIFM, 14 March, 18 May, 13 October and 19 October, unpublished.
5 human repeat insult patch tests aggregated from dermatological literature.
| Test Type | N | Sensitized | Dose µg/cm² | NESIL µg/cm² | Potency |
|---|---|---|---|---|---|
| HRIPT | 101 | 0 | 1417 | 1417 | non-sensitizer |
| HRIPT | - | 0 | 1417 | 1417 | moderate |
| HMT | - | 0 | 64.8 | - | - |
| HMT | - | 0 | 324 | - | - |
| HMT | - | 0 | 1296 | - | - |
Cross-referenced EDC classifications, mechanism data, and dose-response evidence from EDLists, SIN List, and cosmetic-specific detail sources.
weak modulator
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
International Fragrance Association standards per product category. Restriction: Restriction. Effective: 2021-02-10.
| Category | Max % | Category | Max % |
|---|---|---|---|
| 1 (Lip products) | 0.3% | 7a (Deodorant – not spray) | 0.59% |
| 2 (Body spray) | 0.089% | 7b (Deodorant spray) | 0.59% |
| 3 (Body cream) | 0.3% | 8 (Face cream) | 0.099% |
| 4 (Fine fragrance) | 1.2% | 9 (Soap) | 1.4% |
| 5a (Body lotion) | 0.3% | 10a (Household – non-spray) | 1.4% |
| 5b (Face cream leave-on) | 0.29% | 10b (Household – spray) | No Restriction% |
| 5c (Hand cream) | 0.3% | 11a (Intimate – leave-on) | 0.099% |
| 5d (Baby cream) | 0.099% | 11b (Intimate – rinse) | 0.099% |
| 6 (Mouthwash) | 0.29% | 12 (Not for consumer exposure) | No Restriction% |
Preliminary editorial summary for Citral — not a computed safety verdict. See the sourced toxicological data above.
Public NOAEL study rows linked to Citral by CAS number or substance name.
Units vary across source rows: mg/kg bw, mg/kg bw/day
Same-CAS public records found in pharmaceutical and food safety data.
Same-CAS rows from the pharmaceutical spoke database.
Same-CAS food additive or FDA GRAS records from the core public database.
Citral has a safety rating of "MODERATE" in our database. EU status: restricted. US status: permitted. 8 toxicological study endpoint(s) are available in our database. This ingredient has been reviewed by SCCS Opinion.
Citral EU regulatory status: restricted. Maximum allowed concentration: 10 ppm in leave-on products, 100 ppm in rinse-off products. This is based on EU Regulation 1223/2009 and its amendments.
Citral functions as: Fragrance. It is classified as a Fragrance in our database. CAS number: 5392-40-5.
The NOAEL (No Observed Adverse Effect Level) for Citral is 120 mg/kg bw/day based on a Carcinogenicity study via oral route in mouse. A total of 8 study endpoints are available. Source: COSMOS DB.
Citral carries a GHS signal word of "WARNING". Hazard statements: Combustible liquid May be harmful if swallowed or in contact with skin Causes skin irritation May cause allergic skin reaction Toxic to aquatic life. This classification is based on the ILO/WHO International Chemical Safety Card and ECHA C&L inventory data. Note: GHS classification applies to the pure substance — at cosmetic use concentrations, hazard thresholds may not be met.
Citral also appears in industrial chemical safety, pharmaceutical, and food safety data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Check Citral compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Citral in your formulation.